Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Sun BioPharma Q3 EPS $(0.21) Misses $(0.12) Estimate

Author: Benzinga Newsdesk | November 12, 2020 05:22pm
Sun BioPharma (NASDAQ:SNBP) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent.

Posted In: SNBP